RG7652 - Roche
Roche: Union Investment/DVFA, Innovative Strategies in the Life Sciences Sector (Roche) - Jun 19, 2013 - Anticipated NME submission in US and EU for metabolic diseases in 2016 or later 
Anticipated EU regulatory • Anticipated FDA event Dyslipidemia
http://www.roche.com/investors/ir_agenda.htm?tab=2
 
Jun 19, 2013
 
.
 
3917444c-04bb-4bd7-834a-3e74f217493f.jpg